Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Trends in Endocrinology and Metabolism: TEM|June 30, 2007
Endocrine manifestations in Langerhans cell histiocytosisPolyzois Makras, Krystallenia I Alexandraki, George P Chrousos, et al.
Endocrine|February 5, 2021
Immunotherapeutics at the spearhead: current status in targeting neuroendocrine neoplasmsAnna Koumarianou, Gregory A Kaltsas, Eleftherios Chatzellis, et al.
Endocrine-Related Cancer|October 24, 2019
Neoplastic metastases to the endocrine glandsAnna Angelousi, Krystallenia I Alexandraki, George Kyriakopoulos, et al.
Clinical Endocrinology|October 15, 2013
Are patients with autoimmune thyroid disease and autoimmune gastritis at risk of gastric neuroendocrine neoplasms type 1?Krystallenia I Alexandraki, Argiro Nikolaou, Dimitrios Thomas, et al.
Biomolecules|December 30, 2025
Malnutrition and Sarcopenia in Patients with Neuroendocrine Tumors: A Comprehensive Review of EvidenceKalliopi Anna Poulia, Ariadni Spyroglou, Odysseas Violetis, et al.
The Journal of Endocrinology|May 8, 2020
Fixing the broken clock in adrenal disorders: focus on glucocorticoids and chronotherapyMarianna Minnetti, Valeria Hasenmajer, Riccardo Pofi, et al.
Medicine|April 20, 2017
Pancreatic carcinoids (serotonin-producing pancreatic neuroendocrine neoplasms): Report of 5 cases and review of the literatureNikolaos Tsoukalas, Eleftherios Chatzellis, Dimitra Rontogianni, et al.
Minerva Endocrinologica|April 18, 2019
Current concepts in the diagnosis and management of neuroendocrine neoplasms of unknown primary originKrystallenia I Alexandraki, Marina Tsoli, Georgios Kyriakopoulos, et al.
Touchreviews in Endocrinology|February 4, 2022
Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary SyndromeKrystallenia I Alexandraki, Eleni A Kandaraki, Kalliopi-Anna Poulia, et al.
Pageof 11